SUNSHINE PHARMA (06887) appoints Zheng Chengjie as authorized representative.
Dongyang Pharmaceutical (06887) announced that the company's Executive Director and General Manager, Dr. Li Wenjia, will no longer serve as one of the authorized representatives of the company under Rule 3.05 of the Securities Listing Rules of the Hong Kong Stock Exchange. Mr. Zheng Chengjie, the company's secretary, has been appointed as the authorized representative, effective from May 29, 2026.
SUNSHINE PHARMA (06887) announced that Dr. Li Wenjia, the company's Executive Director and General Manager, will no longer serve as one of the authorized representatives of the company under Rule 3.05 of the Securities Listing Rules of the Hong Kong Stock Exchange. Mr. Zheng Chengjie, the company secretary, has been appointed as the authorized representative, effective as of May 29, 2026.
Related Articles
US Stock Market Move | MNSO (MNSO.US) rises more than 5%: Institutions say that profit capabilities are expected to further improve in the next two years.
AI "New Favorite" Ford Motor Company (F.US) stock price is heading towards the largest monthly increase in 17 years. Investors are highly focused on its electric vehicle battery business.
US Stock Market Move | Baidu Inc Sponsored ADR Class A (BIDU.US) rose nearly 5%, Kunlun Chip's business progress is continuous
US Stock Market Move | MNSO (MNSO.US) rises more than 5%: Institutions say that profit capabilities are expected to further improve in the next two years.
AI "New Favorite" Ford Motor Company (F.US) stock price is heading towards the largest monthly increase in 17 years. Investors are highly focused on its electric vehicle battery business.
US Stock Market Move | Baidu Inc Sponsored ADR Class A (BIDU.US) rose nearly 5%, Kunlun Chip's business progress is continuous
